ProfileGDS4516 / 210808_s_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 88% 80% 81% 90% 89% 58% 76% 90% 88% 93% 71% 92% 76% 66% 84% 89% 90% 89% 84% 70% 72% 91% 81% 88% 83% 76% 80% 81% 86% 86% 79% 84% 88% 86% 83% 85% 58% 88% 76% 82% 87% 75% 85% 59% 68% 87% 90% 69% 81% 84% 85% 84% 91% 72% 73% 77% 92% 87% 86% 80% 73% 85% 92% 79% 87% 64% 87% 77% 80% 83% 94% 89% 75% 84% 85% 90% 81% 82% 73% 89% 53% 69% 76% 88% 74% 86% 89% 72% 70% 76% 93% 63% 84% 75% 81% 79% 83% 91% 75% 90% 83% 78% 91% 68% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]9.0672188
GSM537345patient 119, cancer, LCM [OPG study]7.9237680
GSM537355patient 138, cancer, LCM [OPG study]7.9365681
GSM537366patient 154, cancer, LCM [OPG study]9.2979290
GSM537370patient 022, cancer, LCM [OPG study]9.3831789
GSM537380patient 037, cancer, LCM [OPG study]5.9319958
GSM537392patient 077, cancer, LCM [OPG study]7.471176
GSM537415patient 032, cancer, LCM [OPG study]9.4874490
GSM537417patient 042, cancer, LCM [OPG study]8.9083888
GSM537422patient 059, cancer, LCM [OPG study]9.9281493
GSM537423patient 064, cancer, LCM [OPG study]6.9978771
GSM537427patient 084, cancer, LCM [OPG study]9.9692992
GSM537430patient 090, cancer, LCM [OPG study]7.3851976
GSM537336patient 107, cancer, LCM [OPG study]6.592166
GSM537337patient 108, cancer, LCM [OPG study]8.4497684
GSM537348patient 124, cancer, LCM [OPG study]9.129889
GSM537349patient 125, cancer, LCM [OPG study]9.390690
GSM537356patient 139, cancer, LCM [OPG study]9.1289389
GSM537361patient 147, cancer, LCM [OPG study]8.3275184
GSM537374patient 026, cancer, LCM [OPG study]6.7981270
GSM537377patient 033, cancer, LCM [OPG study]6.9952372
GSM537378patient 034, cancer, LCM [OPG study]9.5978591
GSM537379patient 036, cancer, LCM [OPG study]8.0131681
GSM537383patient 046, cancer, LCM [OPG study]9.1275788
GSM537388patient 063, cancer, LCM [OPG study]8.3336683
GSM537395patient 082, cancer, LCM [OPG study]7.5418776
GSM537400patient 099, cancer, LCM [OPG study]7.9983680
GSM537404patient 129, cancer, LCM [OPG study]7.8377781
GSM537409patient 141, cancer, LCM [OPG study]8.8842886
GSM537418patient 044, cancer, LCM [OPG study]8.8634286
GSM537425patient 070, cancer, LCM [OPG study]7.7257279
GSM537333patient 102, cancer, LCM [OPG study]8.3501784
GSM537342patient 116, cancer, LCM [OPG study]9.0546688
GSM537347patient 123, cancer, LCM [OPG study]8.5689486
GSM537350patient 127, cancer, LCM [OPG study]8.2416483
GSM537362patient 148, cancer, LCM [OPG study]8.551885
GSM537363patient 150, cancer, LCM [OPG study]5.8745958
GSM537368patient 156, cancer, LCM [OPG study]8.9225788
GSM537376patient 031, cancer, LCM [OPG study]7.4632276
GSM537381patient 038, cancer, LCM [OPG study]8.1367182
GSM537386patient 057, cancer, LCM [OPG study]8.8098187
GSM537398patient 094, cancer, LCM [OPG study]7.3116775
GSM537402patient 109, cancer, LCM [OPG study]8.5786185
GSM537405patient 130, cancer, LCM [OPG study]6.0366259
GSM537371patient 023, cancer, LCM [OPG study]6.6758568
GSM537421patient 055, cancer, LCM [OPG study]8.8166787
GSM537424patient 065, cancer, LCM [OPG study]9.3350790
GSM537432patient 097, cancer, LCM [OPG study]6.8757769
GSM537331patient 100, cancer, LCM [OPG study]8.0253681
GSM537332patient 101, cancer, LCM [OPG study]8.5423684
GSM537334patient 103, cancer, LCM [OPG study]8.5275885
GSM537338patient 110, cancer, LCM [OPG study]8.4256184
GSM537353patient 135, cancer, LCM [OPG study]9.6213691
GSM537357patient 142, cancer, LCM [OPG study]7.12872
GSM537358patient 143, cancer, LCM [OPG study]7.1263773
GSM537375patient 030, cancer, LCM [OPG study]7.5049777
GSM537389patient 068, cancer, LCM [OPG study]9.9912692
GSM537390patient 072, cancer, LCM [OPG study]8.9977687
GSM537393patient 078, cancer, LCM [OPG study]8.8527486
GSM537399patient 095, cancer, LCM [OPG study]7.8328480
GSM537407patient 133, cancer, LCM [OPG study]7.0876873
GSM537408patient 140, cancer, LCM [OPG study]8.5995885
GSM537428patient 086, cancer, LCM [OPG study]9.6510792
GSM537354patient 136, cancer, LCM [OPG study]7.8492979
GSM537410patient 146, cancer, LCM [OPG study]8.8745487
GSM537413patient 027, cancer, LCM [OPG study]6.4213864
GSM537396patient 083, cancer, LCM [OPG study]8.8653787
GSM537397patient 088, cancer, LCM [OPG study]7.6108577
GSM537330patient 006, cancer, LCM [OPG study]7.9148580
GSM537369patient 015, cancer, LCM [OPG study]8.4358483
GSM537373patient 025, cancer, LCM [OPG study]10.083594
GSM537401patient 106, cancer, LCM [OPG study]9.0968489
GSM537343patient 117, cancer, LCM [OPG study]7.3450475
GSM537367patient 155, cancer, LCM [OPG study]8.4048684
GSM537382patient 041, cancer, LCM [OPG study]8.5198585
GSM537385patient 053, cancer, LCM [OPG study]9.2530890
GSM537391patient 073, cancer, LCM [OPG study]8.0082381
GSM537419patient 045, cancer, LCM [OPG study]8.051382
GSM537420patient 052, cancer, LCM [OPG study]7.1043773
GSM537429patient 089, cancer, LCM [OPG study]9.2779989
GSM537431patient 096, cancer, LCM [OPG study]5.6730753
GSM537387patient 061, cancer, LCM [OPG study]6.7634769
GSM537414patient 028, cancer, LCM [OPG study]7.5008876
GSM537433patient 098, cancer, LCM [OPG study]8.9473988
GSM537335patient 104, cancer, LCM [OPG study]7.2925174
GSM537339patient 111, cancer, LCM [OPG study]8.9110486
GSM537340patient 113, cancer, LCM [OPG study]9.1669689
GSM537344patient 118, cancer, LCM [OPG study]7.0731572
GSM537346patient 011, cancer, LCM [OPG study]6.9062670
GSM537351patient 128, cancer, LCM [OPG study]7.4776976
GSM537352patient 134, cancer, LCM [OPG study]10.058593
GSM537359patient 144, cancer, LCM [OPG study]6.2893663
GSM537360patient 145, cancer, LCM [OPG study]8.4072284
GSM537364patient 152, cancer, LCM [OPG study]7.3378875
GSM537365patient 153, cancer, LCM [OPG study]8.100181
GSM537372patient 024, cancer, LCM [OPG study]7.7169379
GSM537384patient 048, cancer, LCM [OPG study]8.3022783
GSM537394patient 081, cancer, LCM [OPG study]9.6350291
GSM537403patient 121, cancer, LCM [OPG study]7.3097575
GSM537406patient 131, cancer, LCM [OPG study]9.1897990
GSM537411patient 149, cancer, LCM [OPG study]8.1981783
GSM537412patient 019, cancer, LCM [OPG study]7.6909378
GSM537416patient 035, cancer, LCM [OPG study]9.6330991
GSM537426patient 079, cancer, LCM [OPG study]6.7659268